Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech's Ion AmpliSeq Exome CSP Program Adds 12 Members

NEW YORK (GenomeWeb News) – Twelve organizations in the US, Europe, and Asia Pacific have joined Life Technologies' Ion AmpliSeq Exome Certified Service Provider program, bringing total membership to more than 30, Life Tech said today.

The new members are US-based Kashi Clinical Laboratories, RUCDR Infinite Biologics, WuXi AppTec, Molecular Resource Center, and Research and Testing Laboratory; Europe's Fasteris, Eurofins MWG Operon, NIMGenetics, Genomax, and Cellcall; Australia's Lotterywest State Biomedical Facility; and South Korea's DNA Link.

In addition, molecular testing company Cynvenio Biosystems has joined the Ion Certified Service Provider program, of which the Ion AmpliSeq Exome CSP is a part.

In order to be a CSP for AmpliSeq exome sequencing, service providers must demonstrate that they can generate at least 30 million reads per exome using 50 nanograms of starting DNA, cover 88 percent to 90 percent of the exome at 20x, and do the sequencing for an all-in reagents cost of $400. Additionally, providers must be able to sequence two exomes in one two-hour run with a total turnaround time of two days.

"The popularity of the Ion AmpliSeq Exome Certified Service Provider program has grown rapidly, reflecting significant underlying demand for fast, easy-to-use Ion AmpliSeq Exome sequencing," Maneesh Jain, vice president of marketing and business development at Ion Torrent, said in a statement.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.